Midlife health : current concepts and challenges for the future : proceedings of the 5th European Congress on Menopause, held in Copenhagen, 1-5 July 2000 /
Saved in:
| Meeting name: | European Congress on Menopause (5th : 2000 : Copenhagen, Denmark) |
|---|---|
| Edition: | 1st ed. |
| Imprint: | Amsterdam ; New York : Elsevier, 2002. |
| Description: | ix, 230 p. : ill. ; 25 cm. |
| Language: | English |
| Series: | International congress series, 0531-5131 ; no. 1229 |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4694594 |
Table of Contents:
- Preface
- Contents
- I.. Endocrinology, physiology and psychology in mid ages
- Metabolic and endocrine changes in climacteric women
- Psychosocial stress and male gonadal function
- 5-Androgens and postmenopause: effects of 6 months DHEA supplementation in postmenopausal women
- Menopause: loss of self-esteem?
- How to assess quality of life? Aspects of methodology
- Depression in midlife women: what have we learned from longitudinal studies?
- HRT and cognitive function
- Middle-aged men: sexuality and well-being Lecture given on the 5th European Congress on Menopause Copenhagen, Denmark, 1-4 July, 2000
- II.. Osteoporosis
- Techniques for measuring bone mineral density
- Postmenopausal osteoporosis: biochemical markers for monitoring of bone metabolism
- III.. Hormones and cardiovascular disease
- Estrogen and apoptosis in atherosclerosis
- Inflammation in atherosclerosis and acute coronary syndromes
- HRT effects on inflammatory markers: is chronic inflammation a contra-in-dication for HRT?
- Nutritional modification of cardiovascular disease risk
- Hypertension and HRT
- Motion: there is no relation between estrogen deficiency and cardiovascular morbidity. Some introductory remarks by the moderator Dr. Amos Pines to a debate between Dr. John Stevenson (for) and Dr. Trudy Bush (against)
- Long-term hormone replacement therapy use is no longer controversial
- IV.. Breast and endometrium
- Risk of breast cancer with hormone replacement therapy
- Is there a place for progestin agents in breast cancer prevention?
- Managing menopausal symptoms after breast cancer
- Cancer in the family and implications for hormone replacement therapy
- Ultrasound: a useful tool?
- Biopsy techniques
- V.. Wound healing
- Ovarian hormone deficiency and wound healing
- VI.. Information and education
- Clinical use of soy products
- Cimicifuga racemosa: a selective estrogen receptor modulator?
- Attitudes towards menopause and hormone replacement therapy in different cultures
- The Consensus Conference and technical report series
- Whom and how should we inform?
- Author index
- Keyword index
